Dow Up 0.51% Nasdaq Up 0.24%

Grifols, S.A. (GRFS)

-NasdaqGS
36.82 Up 0.26(0.71%) Nov 21, 4:00PM EST
Prev Close:36.56
Open:36.70
Bid:N/A
Ask:40.51 x 100
1y Target Est:40.65
Beta:1.28
Next Earnings Date:N/A
Day's Range:36.56 - 37.21
52wk Range:29.24 - 46.66
Volume:171,573
Avg Vol (3m):783,406
Market Cap:25.19B
P/E (ttm):48.61
EPS (ttm):0.76
Div & Yield:0.20 (0.50%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GRFSUp 0.71%25.19B
HEMA 0.00%1.50M

Key Statistics

Forward P/E (1 yr):14.97
P/S (ttm):6.36
Ex-Dividend Date:05-Jun-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.51
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, Canada, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback